The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
Open accessAbstract
Alzheimer's disease (AD) is a major contributor of dementia leading to the degeneration of neurons in the brain with major symptoms like loss of memory and learning. Many evidences suggest the involvement of neuroinflammation in the pathology of AD. Cytokines including TNF-α and IL-6 are also found increasing the BACE1 activity and expression of NFκB resulting in generation of Aβ in AD brain. Following the interaction of Aβ with microglia and astrocytes, other inflammatory molecules also get translocated to the site of inflammation by chemotaxis and exaggerate neuroinflammation. Various pathways like NFκB, p38 MAPK, Akt/mTOR, caspase, nitric oxide and COX trigger microglia to release inflammatory cytokines. PPARγ agonists like pioglitazone increases the phagocytosis of Aβ and reduces inflammatory cytokine IL-1β. Celecoxib and roficoxib like selective COX-2 inhibitors also ameliorate neuroinflammation. Non-selective COX inhibitor indomethacin is also potent inhibitor of inflammatory mediators released from microglia. Mitophagy process is considered quite helpful in reducing inflammation due to microglia as it promotes the phagocytosis of over activated microglial cells and other inflammatory cells. Mitophagy induction is also beneficial in the removal of damaged mitochondria and reduction of infiltration of inflammatory molecules at the site of accumulation of the damaged mitochondria. Targeting these pathways and eventually ameliorating the activation of microglia can mitigate neuroinflammation and come out as a better therapeutic option for the treatment of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several pathological factors in AD, such as Aβ, pro-inflammatory cytokines, and oxidative stress, activate microglia and initiate downstream signaling pathways such as MAPK, NF-κB, and PI3K/Akt.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The activation of these pathways further promotes the activation of microglia and the production of inflammatory mediators, exacerbating neurotoxicity.238–240”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [240]
The cited source says what the claim attributes to it.
In the citing paper
“A significant trigger for astrocyte reactivity is neuroinflammation, involving pro-inflammatory molecules like cytokines and chemokines (11–14).”
From Varicose projection astrocytes: Conserved reactive cells in brain pathology (2026) · cites this paper as [12]
In the citing paper
“A growing amount of evidence has revealed that a sustained inflammatory state in the brain is a major contributor in the AD pathogenesis (Dhapola et al., 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Dhapola et al., 2021
In the citing paper
“Neuroinflammation has been identified as a key contributor to the pathobiology of AD [2–4]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, H.-Y., Lee, K.-C., Pei, Z., Khan, A., Bakshi, K. P., & Burns, L. H. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.016 · Cited by 48
Retracted2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461 · cited 1×
“Gradually the person becomes bedridden and ultimately leads to death of the Alzheimer’s Association (2019).”
BackgroundNeuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
Alzheimer's disease drug development pipeline: 2018
Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697
Neuroinflammation pathways: a general review
Shabab, T., Khanabdali, R., Moghadamtousi, S. Z., Kadir, H. A., & Mohan, G. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1212854 · Cited by 657
The Alzheimer’s Disease Clinical Spectrum
Atri, A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.009 · Cited by 623
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Aging and Alzheimer's disease pathology
Sengoku, R. (2019) · Neuropathology · doi:10.1111/neup.12626 · Cited by 316
Cited by
Sorted by citations
Items 301–383 of 383
Wang, R., Feng, Y., Zhou, Z., Jiang, J., Zhang, R., Zou, W., Yang, H., Lv, W., & Shen, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1748418 · Cited by 2
Yang, Y., Yang, F., Yao, M., Li, L., & Li, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427028 · Cited by 1
Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implications
Chen, P., Wang, R., Zhou, T., Sun, Y. N., Kirchhoff, F., Miao, Z., & Zhuang, C. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118785 · Cited by 1
Zhong, G., Shi, J., Jiang, Y., Li, S., Wang, X., Zhang, T., Chen, Z., Wang, Q., & Liu, S. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01817-9 · Cited by 1
Kulkarni, R., Kumari, S., Sharma, P., Dhapola, R., Medhi, B., & HariKrishnaReddy, D. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115853 · Cited by 1
Self-citationLi, E., Zhang, P., & Feng, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783786 · Cited by 1
Pharmacological Effects and Molecular Mechanisms of Lignans in the Treatment of Alzheimer’s Disease
Sun, L., Zhu, X., Fan, C., Wang, Y., Chen, Q., Zhang, L., Zhang, Y., & Liu, Y. (2026) · Molecules · doi:10.3390/molecules31152594 · Cited by 1
Begum, M. Y., Rajkumar, M., Govindaraj, P., Prathap, N., Sudha, P. N., Hamod, M. A., Alotaibi, H., & Uvarajan, D. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02381-5 · Cited by 1
Sharma, V., Vashisht, K., Choudhary, G., Choudhay, V., Bhatia, V., Ashawat, M. S., Baldi, A., & Kushawaha, S. K. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02392-2 · Cited by 1
Sharma, A., Feng, L., Muresanu, D. F., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., Bryukhovetskiy, I., Manzhulo, I., Wiklund, L., et al. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_1 · Cited by 1
Scientific Evidence of Baduanjin Improving Cognitive Function in Patients with Cognitive Impairment
唐, 琼. (2024) · Open Journal of Natural Science · doi:10.12677/ojns.2024.122032 · Cited by 1
Catumbela, C. S. G., & Morales, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-65185-z · Cited by 1
Wei, Y., Ming-li, S. U., Ren, D.-L., Zhang, X., Zhu, T., & Yan, X. (2024) · 世界针灸杂志：英文版 · doi:10.1016/j.wjam.2024.04.004 · Cited by 1
Vishnumurthy, R. H., Priya, M. G. R., Tiwari, P. K., & Solomon, V. R. (2024) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024060189 · Cited by 1
Role of oral-gut-brain axis in psychiatric and neurological disorders
Duan, Z.-M., & Wu, L.-F. (2024) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v32.i12.878 · Cited by 1
Mangoni, A. A., & Zinellu, A. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05760-9 · Cited by 1
Marcuzzi, A., Rimondi, E., Melloni, E., Zennaro, F., Sonzogni, A., Leo, S., & Maximova, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073553 · Cited by 1
Sedentary Life Is an Invisible Trap: Molecular, Cellular, and Systemic Reasons to Leave It BehindPreprint
Diniz, D. G., Bento‐Torres, J., da Costa, V. O., Carvalho, J. P. R., Tomás, A. M., de Oliveira, T. C. G., Soares, F. C., de Macedo, L. D. E. D., Jardim, N. Y. V., Bento-Torres, N. V. O., et al. (2024) · Preprints.org · doi:10.20944/preprints202408.1277.v1 · Cited by 1
Gene-expression control in early and late-onset dementia
Zhou, J. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9465
Shuzhen, L., Wu, W., Hongyan, G., Ruiying, W., & Mulud, Z. A. (2022) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2022.990
Fu, X., Wang, X., Lai, Y., Cai, C., Liao, Y., Dai, Z., Xu, H., Fang, S., & Fang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2535968/v1
Du, Y., Zhang, M., Chen, M., Hu, M., Zeng, W., Zhang, W., Zhu, J., & Yang, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3310697/v1
Nanomedicines in the Treatment of Nervous System Disorders
Zeb, Z., Sharif, A., Abdel‐Daim, M. M., Anjum, S. M. M., Khalil, A. A. K., Akhtar, M. F., Saleem, A., & Khan, M. I. (2023) · Learning materials in biosciences · doi:10.1007/978-981-99-7626-3_5
Iwai, M., Nakaoji, K., Hamada, K., Inaba, Y., Muraoka, K., Tohsuji, E., & Jinnin, M. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s440336
Padrões evolutivos da interleucina-6 (il-6) e seu impacto para a saúde humana
de Freitas, A. F. F., de Freitas, N. S. A., Mariano, M. H. Q. D. A., Rushansky, E., & Maia, M. D. M. D. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-374 · Cited by 1
Wang, J., Qu, Y., Huang, Y., Zeng, H., Chui, E., & Yao, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3909570/v1
Evolutionary patterns of interleukin-6 (Il-6) and its impact on human health
de Freitas, A. F. F., de Freitas, N. S. A., Mariano, M. H. Q. D. A., Rushansky, E., & Maia, M. D. M. D. (2024) · Seven Editora eBooks · doi:10.56238/sevened2024.007-030
L-NRB alleviates amyotrophic lateral sclerosis by regulating P11-Htr4 signaling pathway
Pan, Y., Sun, X., Yu, T., Yu, M., Luo, Y., & Sun, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117588
Udagatti, V. D., Kumar, R. D., Rao, A. G., & Sowmya, S. M. (2024) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-024-05200-x
Pereira, J. D., Tosatti, J. A. G., & Gomes, K. B. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_484
Wang, P., Dong, Y.-L., Li, S.-S., Jin, Y., Sun, W., Zhao, B., Li, Q.-B., & Chen, X. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241305744
田, 瑞. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153877
Yuan, S., Gaamouch, F. E., Cho, S., Kuncewicz, K., Nada, H., & Gabr, M. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.22.660908
Blood Interleukin-6 (IL-6) mRNA Expression in Alzheimer’s Disease: A Preliminary AnalysisPreprint
Hashim, M. E. (2025) · medRxiv · doi:10.1101/2025.07.13.25331470
Relação estrutura-atividade da fisalina B em alvos biológicos associados à doença de Alzheimer
da Mota, B. V., da Silva, V. B., Ayres, T. C. P., de Aquino, V. M., Filho, J. A. C., Sousa, K. D. P., & Ataídes, J. V. B. D. Q. E. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n10-046
Yuan, C., Lv, S., Han, Y., Li, Y., Xian, Z., Liu, G., & Xiao, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c05682
GPR55 deficiency exacerbates cognitive impairments and Alzheimer's disease-like pathology in mice
Fan, B., Liang, Y., Zhi, T., Wu, L., Wu, Y., Yang, Y., Xie, Z., & Wu, X. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106105
Lo, T. Y., Chan, A. S. L., Cheung, S. T., Yung, L. Y., Leung, M. M. H., & Wong, Y. H. (2024) · Figshare · doi:10.6084/m9.figshare.26610666
Additional file 2 of Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice
Guo, J., Kong, Z., Yang, S., 达静静, Chu, L., Han, G., Liu, J., Tan, Y., & Zhang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722239
Additional file 1 of Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice
Guo, J., Kong, Z., Yang, S., Da, J., Chu, L., Han, G., Liu, J., Tan, Y., & Zhang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722236
Chen, C.-S., Hsu, Y.-A., Lin, C., Wang, Y.-C., Lin, E.-S., Chang, C.-Y., Chen, J. J.-Y., Wu, M.-Y., Lin, H.-J., & Wan, L. (2022) · Figshare · doi:10.6084/m9.figshare.21340408
Research Prospects for mTOR in Neuroinflammation: A Bibliometric Analysis
Liang, L., Wang, M., Liu, Z., & Wang, S. (2026) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273398806251024072412
Research Progress on Targeted Inhibition of Ferroptosis and Alzheimer's Disease Treatment
Liu, A., Li, J., Gao, W., Li, X., Song, J., Xing, L., & Li, H. (2026) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575411431251125115235
Silk fibroin@polydopamine for acupoint catgut-embedding therapy in Alzheimer’s disease
Wang, C., Liu, X., Fan, Y., Liu, G.-Y., Wu, P., Li, S.-C., & Du, Y. (2026) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2026.01.010
Trends and Research Frontiers in Mammalian Target of Rapamycin and Alzheimer’s Disease
Ma, Z., Xiao, Z., Yang, Z., Huang, B., & Wang, X. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05714-1
Tang, X., Wang, Y., Wang, L., Tian, X., & Sun, C. (2026) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.5c07559
Abdelrahman, K. S., Soltan, O. M., Mansour, H. E. A., Nofal, A. E., Eissa, E. A., Salem, H. R., Mahfouz, M. M., El‐Adawy, S. A., Ewies, G. S. A., Hamdi, A., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118738
Zhang, Y., Jiang, H., Zhang, F., & Liao, J. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00234
Su, R., & Yang, Q.-Y. (2026) · New cell · doi:10.61958/ncjg8269
Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
Luckett, P. H., Petersen, M. E., O’Bryant, S. E., Mapstone, M. E., Christian, B. T., Handen, B. L., Head, E., & Ances, B. M. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70325
Li, X., Meng, L., Niu, Q., Ma, R., Li, Y., Zhou, H., Fu, X., Chen, W., Tang, J., & Xu, S. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103452
Psychometric criteria for superior cognitive performance in very old adults
Malek‐Ahmadi, M. H., Perez, S. E., He, B., Rogalski, E. J., Counts, S., Ikonomović, M. D., Abrahamson, E. E., Ginsberg, S. D., Alldred, M. J., Serrano, G. E., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261435166
Fu, X., Huang, J., Liu, Y., Li, H., & Zhang, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1797302
Wang, Y., Wang, Q., Xie, H., Liu, X., Ju, Y., Liu, X., & Sun, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1806181
Xie, M., Niu, X., Sun, F., & Shi, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261443968
Decoding Pathogenic Mutational Landscapes in Alzheimer′s Disease Through Integrated Transcriptomics
Ma, W., Zhou, F., Cai, H., & Fang, L. (2026) · Human Mutation · doi:10.1155/humu/6627566
The bidirectional mechanistic links between Alzheimer’s disease and cardiovascular disease
You, J., & Yang, J. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09151-9
Liu, L., Yang, D., & Fu, J. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s601127
Muraleva, N. A., Stefanova, N. A., & Kolosova, N. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125430
Targeting serine/threonine kinases: therapeutic innovations for neurodegenerative disorders
Chang, Y., Zhu, J., Sun, X., Wei, A., Yan, Y., Wang, H. W., & Kong, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00005-x
Belahusna, D. F., Santoso, P., & Rahayu, R. (2026) · Biointerface Research in Applied Chemistry · doi:10.33263/briac163.075
Xing, X., Wang, K., Feng, Y., Wu, C., Jia, L., Li, H., Wen, Z., Tang, Y., Wang, Z., Zhang, X., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1822543
Wang, J.-Q., Hu, B.-B., Wang, Y., Lu, Y.-W., Gong, X., Tang, S., Song, L.-J., Sun, Y., Zhang, J.-T., Wang, Z., et al. (2026) · Nutrients · doi:10.3390/nu18132071
Zhang, R., Gao, X., Wang, H., & Wang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1853257
Couto, C. D. O. P., das Eiras, M. L. H., de Morais, J. L. J., Júnior, C. W. L. C., Forlenza, O. V., & de Paula, V. D. J. R. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06030-4
Diverse roles of connexins in the neuro-vasculature in homeostasis and disease
Delobel, V., Genet, N., & Hirschi, K. K. (2026) · Translational Neuroscience · doi:10.1515/tnsci-2025-0400
Zou, Y., Huang, J., Yin, J., Liu, L., Zhou, H., Song, B., Wang, Y., Wang, M., Wang, L., Kong, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1837418
Bernardes, L. M. M., Marquez, A. S., Mascarenhas, F. N. A. D. P., de Freitas, L. F., Ferreira, D. C., Malta, S. M., Moreira, A. S., Mendonça, T. P., de Sousa, J. N. B., Silva, I. F., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119774
Dhapola, R., Sharma, P., Kumari, S., Vellingiri, B., & HariKrishnaReddy, D. (2026) · Ibrain · doi:10.1002/ibra.70027
Self-citationWang, Q., Feng, N., & Zhang, Y. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c06159
Wu, Y., Xu, Q., Qin, Z.-H., Wu, X., Hu, Z., Yang, W., Ren, P.-Y., Tian, Y.-Y., Lin, Z., & Xian, Y. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01896-5
Gönüllü, S., Dalkılınç, E., Çelik, O., ÇELİK, H., Küçükler, S., Topal, A., Akay, R., Yıldız, M. O., Alım, B., & Özdemir, S. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00823-0
Transcriptomic signatures as biomarkers for the progression of mild cognitive impairment
Yang, J., Li, J., 毛柳元, Ren, H., Li, Q., Geng, X., Lu, Q., Peng, C., Zhang, J., Liu, X., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1901264
Jucha, J., Zając, D., Darasz, D., Łukawski, A., Slobozheniuk, L., Bieniak-Pentchev, M., Kaczorek, M., Machnik, K., Dziewięcka, O., & Ziębka, W. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6010
Liu, A., Xing, L., Li, J., Gao, W., Yao, M., Song, J., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103352
Hussain, A., Hussain, R., Sarfraz, H., Azam, U., Hasnat, M., Khan, S. A., Rana, S. M., Asiri, Y. M., & Zainab (2026) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-026-00939-7
Wang, J., Chong, M., Xie, Y., Wang, S., Hu, Z., Jie, H., Mu, J., 段飞鹏, & Huang, L. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05936-z
Fakorede, S., Lateef, O. M., Udefa, A. L., Ajagbe͓, A. O., Roy, S., Akosile, P. O., Awobona, T. A., & Anyanwu, G. E. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06237-5
Moaty, M. N. A. A., Moustafa, A., Hegazy, A. S., Sobhy, A. A., Ghareeb, D. A., Awad, L. F., & Ibrahim, N. A. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110578
Dhapola, R., Kumari, S., Sharma, P., Paidlewar, M., Vellingiri, B., Cho, S.-G., Dayem, A. A., Medhi, B., & HariKrishnaReddy, D. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02418-9
Self-citationPiplani, M., Thakur, S., Kumar, P., Garg, S. S., Goyal, A., & Goyal, P. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3483
Samantaray, P., & Verma, P. (2026) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2026.104130
Metadata
- Authors
- Dhapola, R., Hota, S. S., Sarma, P., Bhattacharyya, A., Medhi, B., & Reddy, D. H.
- Affiliations
- Central University of Punjab (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- Government Medical College and Hospital (IN)
- Venue
- Inflammopharmacology
- Published
- 2021-11-23
- Volume
- 29
- Issue
- 6
- Pages
- 1669-1681
- ISSN
- 0925-4692 (ISSN-L)
- 1568-5608
- PMC
- PMC8608577
- OpenAlex
- W3215739089
- Cited by
- 383
- References
- 61
- Citations by year
- 2026: 72 · 2025: 116 · 2024: 111 · 2023: 55 · 2022: 27
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Inflammopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, microglia, amyloid-beta, NF-κB, TNF-α, interleukin-6, p38 MAPK, caspases, nitric oxide, COX-2 inhibitors, PPARγ agonists, pioglitazone, celecoxib, rofecoxib, indomethacin, mitophagy, astrocytes
- MeSH terms
- Neuroinflammatory Diseases, Alzheimer Disease, Animals, Humans, Inflammation, Mitochondria, Cytokines, Inflammation Mediators, Molecular Targeted Therapy, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
